VP-102
-
FDA Voices Concerns About West Chester-Based Pharma Company’s Lead Drug Candidate
West Chester-based Verrica Pharmaceuticals saw its stock plunge by nearly 22 percent after the FDA voiced concerns about its lead drug candidate, VP-102, writes John…
-
West Chester Pharma Firm’s New Drug May Become Standard of Care for Common Skin Disease
Verrica Pharmaceuticals in West Chester is seeking approval from the Food and Drug Administration for a new drug to treat molluscum contagiosum, a common and…













































